Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders
- 1 April 2006
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 29 (2-3), 397-404
- https://doi.org/10.1007/s10545-006-0265-4
Abstract
Tandem mass spectrometry is currently used in newborn screening programmes to quantify the level of amino acids and acylcarnitines in dried blood spots for detection of metabolites associated with treatable diseases. We have developed assays for lysosomal enzymes in rehydrated dried blood spots in which a set of substrates is added and the set of corresponding enzymatic products are quantified using tandem mass spectrometry with the aid of mass-differentiated internal standards. We have developed a multiplex assay of the set of enzymes that, when deficient, cause the lysosomal storage disorders Fabry, Gaucher, Hurler, Krabbe, Niemann–Pick A/B and Pompe diseases. These diseases were selected because treatments are now available or expected to emerge shortly. The discovery that acarbose is a selective inhibitor of maltase glucoamylase allows the Pompe disease enzyme, acid α-glucosidase, to be selectively assayed in white blood cells and dried blood spots. When tested with dried blood spots from 40 unaffected individuals and 10–12 individuals with the lysosomal storage disorder, the tandem mass spectrometry assay led to the correct identification of the affected individuals with 100% sensitivity. Many of the reagents needed for the new assays are commercially available, and those that are not are being prepared under Good Manufacturing Procedures for approval by the FDA. Our newborn screening assay for Krabbe disease is currently being put in place at the Wadsworth Center in New York State for the analysis of ∼1000 dried blood spots per day. Summary We have developed tandem mass spectrometry for the direct assay of lysosomal enzymes in rehydrated dried blood spots that can be implemented for newborn screening of lysosomal storage disorders. Several enzymes can be analysed by a single method (multiplex analysis) and in a high-throughput manner appropriate for newborn screening laboratories.This publication has 25 references indexed in Scilit:
- Tandem Mass Spectrometric Analysis of Dried Blood Spots for Screening of Mucopolysaccharidosis I in NewbornsClinical Chemistry, 2005
- Fabry disease and the heart: an overview of the natural history and the effect of enzyme replacement therapyActa Paediatrica, 2005
- Enzyme replacement therapy in mucopolysaccharidosis type IActa Paediatrica, 2005
- Fabry disease and the heart: an overview of the natural history and the effect of enzyme replacement therapyActa Paediatrica, 2005
- Enzyme replacement therapy in mucopolysaccharidosis type IActa Paediatrica, 2005
- Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn ScreeningClinical Chemistry, 2004
- Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)The Journal of Pediatrics, 2004
- Tandem Mass Spectrometry for the Direct Assay of Enzymes in Dried Blood Spots: Application to Newborn Screening for Krabbe DiseaseClinical Chemistry, 2004
- Ordered-Subsets Linkage Analysis Detects Novel Alzheimer Disease Loci on Chromosomes 2q34 and 15q22American Journal of Human Genetics, 2003
- Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-α-glucosidase in human fetal and adult tissues and cultured cellsClinica Chimica Acta; International Journal of Clinical Chemistry, 1985